Bryan

SMC Announces Marketing Agreement with Plato Technologies. Inc.

Source Node:
Time Stamp: April 19, 2024 5:45 AM - Modified On: April 19, 2024 - Published By:
Source Cluster:
Republished By Plato

  BOCA RATON, FL / Plato / Amplifi / April 18,2024 / SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK: SMCE) SMC / (PINK:SMCE) is pleased to announce a marketing agreement and collaboration with Plato Technologies Inc. Plato Technologies specializes in AI content disruption and AI management systems. The collaboration will enable the Company to market Plato's platform directly to web and content development teams. The companies have agreed on a revenue sharing agreement after deducting individual client acquisition costs. "This is just the beginning." stated Erik Blum CEO

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

Source Node:
Time Stamp: February 7, 2024 10:49 AM - Modified On: February 7, 2024 - Published By:
Source Cluster:
Republished By Plato

Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio industry welcomed the parliament’s passage of a bill that adds regenerative medicine organizations to the list of those considered for human cell management business licenses. The National Assembly passed the “Amendment to the Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals” in a plenary session paving the way for certain next generation NK Cell Therapy companies to recognized as a licensed

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

Source Node:
Time Stamp: January 29, 2024 6:55 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Plato Data Intelligence Leverages Vectara to Power its Data-As-A-Service / DaaS Platform

Source Node:
Time Stamp: January 18, 2024 1:36 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

From development to launch, Vectara’s GenAI technology and team help innovators get to market faster. The announced partnership breaks new ground towards deploying a next generation of GenAI tools with Vertical focus. Vectara, the Trusted Generative AI Product Platform, and Plato Data Intelligence, creators of PlatoAi, have entered into a commercial agreement to unlock the power of Vectara via Plato AI’s Generative Intelligence platform. With an emphasis on secure, trustworthy, and transparent GenAI for enterprises, Vectara was the clear choice for developers who want a trusted provider to count on

Koat.ai and Plato AI Announce Strategic Partnership to Revolutionize Data Intelligence and Drive Innovation.

Source Node:
Time Stamp: November 10, 2023 6:06 AM - Modified On: November 10, 2023 - Published By:
Source Cluster:
Republished By Plato

New York, USA November 9, 2023.  Koat.ai, a next-generation social listening and intelligence platform, and Plato AI, a pioneer in open intelligence solutions, announced today a strategic partnership aimed at transforming the landscape of data intelligence and innovation. At the forefront of data intelligence, Koat.ai is a comprehensive and actionable market insights platform powered by AI. The company's proprietary manipulation detection technology enables it to identify both human and manipulated (inorganic) accounts, providing unparalleled clarity of insight and data. With granular sentiment analysis, quantified emotions, and real-time abnormality alerts, Koat.ai

PureTalk AI Collaborates with Plato AI to Launch Innovative WebApp Empowering Conversational AI.

Source Node:
Time Stamp: November 8, 2023 5:03 AM - Modified On: November 8, 2023 - Published By:
Source Cluster:
Republished By Plato

November 7, 2023. New York, NY – Puretalk AI, a leading provider of advanced conversational AI solutions, is thrilled to announce its exciting collaboration with Plato, a pioneer in machine learning and AI technology. Together, they are launching a cutting-edge website Widget designed to revolutionize the way websites engage with visitors. This groundbreaking widget, which leverages Puretalk AI's machine learning capabilities and humanized Text-to-Speech (TTS+) technology, will transform static websites into interactive, conversational platforms. The new website Widget, aptly named "Socrates," has been engineered to dynamically learn and adapt to

Clinical Squared and PlatoHealth Join Forces to Revolutionize Healthcare with Advanced Data Orchestration Powered by AI.

Source Node:
Time Stamp: September 20, 2023 12:28 PM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington DC, September 20th, 2023 — Clinical Squared (C2) and Platohealth.ai are delighted to announce a groundbreaking partnership that promises to reshape the healthcare landscape. Their collaboration brings together the healthcare expertise of C2 and the cutting-edge AI and machine learning capabilities of Plato.ai to create innovative solutions. [gallery columns="2" link="none" size="large" ids="2281765,2281767"] Clinical Squared, a leader in healthcare market expertise, data architecture, software development, consultation and implementation services, will lend its extensive industry knowledge to Plato.ai's platform. In turn, Plato.ai will provide advanced AI and machine learning mechanisms to

Government Blockchain Association (GBA) Deploys PlatoAi across GBA’s Opensource Intelligence Platform (OSINT)

Source Node:
Time Stamp: July 6, 2023 11:44 AM - Modified On: July 6, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington DC, July 6th, 2023. Government Blockchain Association (GBA) announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the GBA Members Site. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption, standards and regulatory compliance of global government blockchain initiatives. Through this deployment GBA’s community will immediately benefit by accessing the latest premium intelligence across 36 Market Verticals including Ai, Digital Assets, Regulatory Initiatives, Web3, NFT’s, CyberSecurity, ESG and Carbon Offsets.

Erez Capital Announces the Addition of 40 Venture Partners and $10M Commitment

Source Node:
Time Stamp: June 22, 2023 10:01 AM - Modified On: June 22, 2023 - Published By:
Source Cluster:
Republished By Plato

FOR IMMEDIATE RELEASE June 22, 2023 Press Contact: Noah Ente Associate Erez Capital noah@erezcapital.io  Boston, June 23, 2023 - Erez Capital, a emerging venture capital fund investing in disruptive technologies, is thrilled to announce its addition of 40 Venture Partners to join the fund. These new partners will play an important role in the quickly developing artificial intelligence ecosystem - specifically in the proptech, medtech and fintech sectors. “This is an exciting new chapter for Erez Capital, creating a new collaborative model to drive rapid acceleration and growth for pre-seed

Redmatter.Capital Deploys PlatoAi across its Web3 Content and Data Intelligence

Source Node:
Time Stamp: June 12, 2023 11:56 AM - Modified On: June 12, 2023 - Published By:
Source Cluster:
Republished By Plato

Montenegro, June 10th, 2023. Redmatter.Capital a fully regulated platform digital assets today announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the Redmatter Platform. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption and regulatory compliance of Digital Assets. Through this deployment Redmatter’s community of users will immediately benefit by accessing the latest premium intelligence across the digital asset sector including Web3, NFT’s, Trading and Carbon Offsets. Both companies plan to

Plato Reaches 10M Visitor Mark.

Source Node:
Time Stamp: January 25, 2023 4:28 AM - Modified On: January 25, 2023 - Published By:
Source Cluster:
Republished By Plato

Plato hits the 10 millionth Visitor Mark andLays out Web3 Vision at Quantum Miami. Jan 25th Miami FL - Plato Technologies Inc. (Plato) announced today that it has passed the 10 millionth visitor mark on their Open Beta.  “This represents significant milestone for the company and we want to thank everyone involved in this project for their contributions over the course of the last three years of bootstrapping.” states CEO Bryan Feinberg.  The company who has been operating somewhat in stealth mode for the past 3 years is presenting this